There are a handful of reasons: 1) Obesity : 1 in 8 is obese worldwide, doubled since 1990 2) Usage : increasing into apnea, kidney and heart health, in testing for cancer & addiction 3) Ease : pills will bring down costs and increase usage 4) Innovation : new drugs bring greater weight loss, fewer side effects and unique action 5) Cost : pills, generics, subsidies, insurance and increased competitors all drive price down Q: Is GLP-1 a trend that is likely to stay or is the bubble about to burst
Accountability: Create accountability for yourself, whether through tracking food and movement or sharing your journey
However, insurance rarely covers compounded tirzepatide costs but may cover standard tirzepatide if you meet certain diagnostic criteria
In secondary analyses within the GLP-1RA group, continued use was compared with the other scenarios
Amino acid catabolism increases, generating heat as a byproduct